🦊/Investors

Inkef

Venture capital

Amsterdam · Seed–Growth · 10 people tracked

Also known as INKEF Capital

Find your way into Inkef

2,314 people in our graph share verified history with the Inkef team — schools, employers, funds. One of them is your warm intro.

Javier Solterounlockedknows Ryan Sarver · together at Redpoint Ventures (overlapped)
knows the team · via Twitter
×2knows the team · via Motherduck
×2knows the team · via Remote
knows the team · via GitLab
×2knows the team · via Stealth Startup
Fox Verdict
Sign up to see your fit

Investment thesis

Inkef positions itself as an early-stage, hands-on investor that partners closely with companies to help build them into businesses with global reach. The firm emphasizes creating true value and sustainable returns through a long-term strategic vision rather than short-term gains.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Growth
HQ
Amsterdam, NL
Leads rounds
Follows
Instruments
Equity
Founded
2010
Last 12 months
1 investment
AUM
$540M
Tracked investments
51
Unicorns
2
IPOs
1
Acquisitions
2

Team · 10 people

from the firm's website & public directories

What they invest in

from 39 of 51 portfolio companies

Biotech ×16Medical Devices ×15Healthtech ×12Deep Tech ×11Digital Health ×8AI & Machine Learning ×7SaaS ×7Fintech ×5

HQs:Netherlands×12United States×5Denmark×2Belgium×1Germany×1Spain×1

Investments · 51 tracked

founders shown can be your intro path

By year:2026 · 12025 · 42024 · 52023 · 32022 · 42021 · 22018 · 12016 · 22015 · 123 dated

GitLabgitlab.comin𝕏NASDAQ: GTLB

GitLab is an intelligent orchestration platform for DevSecOps that enables teams and AI agents to collaborate on the full software development lifecycle, from planning through deployment, with integrated security and compliance capabilities.

AI & Machine LearningCybersecurityDeveloper ToolsEnterprise SoftwareSan Francisco, US

Sid Sijbrandij(Founder/CEO)inDmytro Zaporozhets(Founder/CTO)inDmitriy Zaporozhets(Cofounder)Paul Machle(Executive Officer)in

BoardBruce Armstrong(Director)in

Co-investorsAlkeon InnovationAugust CapitalBase PartnersBling CapitalCategory VenturesCoatue Management+22 more

Draupnirdraupnir.bioinSeed · Jul 2024 · $13M✓ verified

Draupnir Bio develops targeted protein degradation therapies using sortilin-based lysosome targeting chimeras to clear extracellular and membrane-bound protein aggregates in proteinopathies.

BiotechDeep TechMedical DevicesCopenhagen, DK

Simon Glerup(Professor)inCamilla Gustafsen(Professor)inPeder Søndergaard Madsen(Professor)Peter Seeberger(Professor)

Co-investorsGilde HealthcareMC Healthcare VenturesNovo Holdings

iOncturaionctura.comin𝕏Series B · Jun 2024 · $86M✓ verified

iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.

BiotechDeep TechHealthtechMedical Devices

Catherine Pickering(Co-Founder & CEO)inLars van der Veen(Co-Founder & CSO)inMichael Lahn(CMO)inElizabeth Holt(CBO)inSteven Sciuto(CFO)inMichelle Tsai(COO)in

Co-investors3B Future Health FundM VenturesVI PartnersXGEN VentureJohnson & Johnson Innovation – JJDC

VarmXvarmx.cominMay 2023✓ verified

VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.

BiotechHealthtechMedical Devices

Pieter ReitsmainJohn Glasspool(Chief Executive Officer)in

Co-investorsSound BioventuresYsios CapitalBioGeneration VenturesEICEQT Life SciencesUNIIQ+2 more

Aidenceaidence.comin

Aidence, founded in 2015 in Amsterdam, was a radiology AI company that built clinical applications to help radiologists and physicians interpret medical images, focused on pulmonary nodule management and lung cancer screening.

AI & Machine LearningHealthtechMedical DevicesAmsterdam, NL

Co-investorshenQ vcNorthzone

Ambagon Therapeuticsambagontx.comin𝕏Jan 2025

Ambagon develops small molecule stabilizers of 14-3-3 protein complexes to modulate disease-related protein interactions, targeting therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.

BiotechDeep TechMedical DevicesEindhoven, US

Christian Ottmann(Executive Officer)inJosh Seidenfeld(Executive Officer)Michelle Arkin(Director)Nancy Pryer(Executive Officer)Margarita Chavez(Director)Bryan Miller(Executive Officer)

Co-investorsDroia VenturesMission BiocapitalMRL Ventures FundNextech InvestRA Capital

Anavotxanavotx.comin𝕏

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable.

BiotechHealthtechLeiden, NL

Birgit Zech(CEO)in

Co-investorsTaiho Ventures, LLCBioqube VenturesM Ventures

Audiontherapeuticsaudiontherapeutics.comin

Audion Therapeutics is developing treatments for hearing restoration and related conditions by leveraging cellular regeneration research.

BiotechDigital HealthHealthtechMedical Devices

Helmuth van Es(Co-founder)Rolf Jan RuttenPeter Weber(Chief Medical Officer)Leonie MiddelinkAlbert Edge(Professor of Otolaryngology-Head and Neck Surgery, Harvard Medical School)

Baserowbaserow.ioin𝕏Jul 2022

Baserow is an open-source low-code platform that allows users to build databases and applications without coding.

Cloud ComputingData & InfrastructureDeveloper ToolsSaaS

Bram Wiepjes(Founder)in

Co-investorsFrontline Venturesfirstminute capital

BioClin Therapeuticsin

BiotechSan Leandro, US

Steve Abella(Chief Medical Officer)inGraeme Currie(Chief Operating Officer)inStephen W. Lau(President, Chief Executive Officer, and Treasurer)inKenneth Schwartz(Executive Officer)inEric Yuen(Executive Officer)inMarten Steen(Director)in

Co-investorsHealthCapSectoral Asset ManagementSofinnova VenturesYsios Capital

Bloomonbloomon.nlSeries A · Sep 2015 · $4M
Cardior Pharmaceuticals GmbHcardior.deSeries B · Aug 2021 · $75M

Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.

Co-investorsBioMedPartnersHadean VenturescoparionFund+LSP (Life Sciences Partners)Sunstone Capital

Cashforcecashforce.cominMar 2024Acquired

Belgian cash forecasting and working capital analytics software provider, acquired by Treasury Intelligence Solutions in 2022.

FintechAntwerpen, BE

Co-investorsTechstarsCiti VenturesPamica NVVolta Ventures

Castorcastoredc.cominSeed · Jul 2018 · $6M

Castor provides a clinical trial data platform that combines electronic data capture, AI-assisted source data extraction with human review, and real-world evidence collection for medical device manufacturers, biopharma, diagnostics, and academic research teams.

AI & Machine LearningCloud ComputingData & InfrastructureDigital HealthHealthtechMedical DevicesSaaSAmsterdam, NL

Derk Arts(Founder)in

Co-investorsF-Prime CapitalChartered GroupTwo Sigma Ventures

Channelenginechannelengine.comin𝕏

ChannelEngine is a platform that enables ecommerce sellers to manage product data, inventory, orders, pricing, and fulfillment across multiple marketplaces from a single interface.

B2B MarketplacesE-commerceRetail TechSaaSLeiden, NL

Jorrit Steinz(CEO and founder)

Co-investorsAtomicoGeneral Catalyst

Corporis Medicalcorporis-medical.comin

Corporis Medical develops medical devices for surgical and diagnostic applications, focusing on innovations like perfusion measurement systems and clinical validation.

BiotechDeep TechDigital HealthHealthtechMedical DevicesMaastricht, NL

Alexander Veenhof(Surgeon, MD, Founder)

Co-investorsBrightlands Venture Partners

Dialecticdialectic.com𝕏May 2024

Dialectic combines machine intelligence with crypto-native financial tools to build automated financial compounding systems.

AI & Machine LearningCrypto & Web3Fintech

Ryan Zurrer(Founder)in

Co-investorsMarin Digital Ventures

EclecticIQeclecticiq.comin𝕏Series A · May 2016 · $6M

EclecticIQ builds a threat intelligence platform powered by AI to help organizations address cybersecurity challenges.

AI & Machine LearningCybersecurityEnterprise SoftwareAmsterdam, NL

Cody Barrow(Chief Executive Officer)in

Co-investorsCapricorn Venture PartnersCuriosity VCKeen Venture PartnersKPN VenturesTIIN Capital

Geophygeophy.comSeries A · May 2016
Happeohappeo.comin𝕏Jul 2022

Happeo is an intranet and enterprise search platform that integrates with Google Workspace and Microsoft 365, letting departments build no-code pages while IT retains security governance.

Enterprise SoftwareFuture of WorkSaaS

Co-investorsDN CapitalEndeit CapitalEvli Growth PartnersSmartFinVendep CapitalMaki.vc

Hellokaleidohellokaleido.comin

ViCentra develops Kaleido, a compact and user-friendly insulin pump system for people with Type 1 diabetes.

Digital HealthHardwareMedical DevicesUtrecht, DE

Tim Oakes(CTO and Co-founder)

Co-investorsEQT Life SciencesInnovation Industries

InteRNAinterna.bio

Interna develops a molecular delivery platform that transports large molecule therapeutics such as DNA, RNA, and proteins across cell membranes to treat infectious and non-infectious diseases.

AI & Machine LearningBiotechDeep TechMedical Devices

Roger D. Kornberg(Scientific Leader)

Co-investorsAurora Science

Kinaset Therapeuticskinasettherapeutics.comin𝕏Series B · Jan 2026 · $100M

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesSixty Degree CapitalVivo Capital+3 more

Mosannamosanna.comSeries A · Jun 2025 · $80M

Mosanna is a pharmaceutical company developing a non-invasive nasal spray therapy for obstructive sleep apnea (OSA) that reactivates the body's natural airway reflex to keep the upper airway open during sleep.

BiotechDigital HealthHealthtechMedical Devices

Barbara(Regulatory Affairs & Quality Assurance leadership)Kevin(Pharmaceutical Development leadership)Pranav(Head of Finance & Operations)Ben(Executive / Board)

BoardDavid White(Sleep Medicine Advisor)

Co-investorsBroadview VenturesNorwest Venture PartnersSupermoon CapitalHTGFPivotal Life Sciences

NMD Pharmanmdpharma.comin𝕏Nov 2023 · $81.3M

NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions.

BiotechDeep TechHealthtechMedical DevicesAarhus, DK

Co-investorsJeito CapitalNovo HoldingsRoche Venture Fund

Npexnpex.nlin𝕏

NPEX operates a securities exchange in the Netherlands that connects businesses seeking financing with investors, having facilitated over €217 million in funding across more than 100 financings.

FintechMarketplaces

Co-investorsPeak

Oneone.fitinacquired by Urban Sports Club

MarketplacesSports TechWellness & Fitness

Co-investorsPeakConnecticut InnovationsInspired CapitalMercury Fund

Onwdonwd.com

ONWARD Medical develops non-invasive and investigational spinal cord stimulation therapies to restore hand sensation, strength, and function in people with spinal cord injury.

HardwareHealthtechMedical Devices

Co-investorsRunway Growth Capital

Polarstepspolarsteps.comin

Polarsteps is an app that helps travelers plan, track, and share their journeys on a world map, serving explorers and adventure seekers worldwide.

ConsumerSocialTravel & HospitalityAmsterdam, NL

NiekJobClare(CEO)

Co-investorsCuriosity VCRiver Venture PartnersFuture Food Fund

PRECIRIX NVprecirix.comSeries B · Mar 2022 · $88M

Co-investorsBioMedPartnersHealthCapPontifax Venture CapitalV-Bio Ventures

Provablelabsprovablelabs.comin

Provable Labs provides trading and trade management solutions for the securities lending market, offering marketplace and lifecycle management tools for the front, middle, and back office.

Enterprise SoftwareFintechSaaS

Quantum Motionquantummotion.tech

Quantum Motion develops utility-scale quantum computers using silicon spin-qubit architecture compatible with standard semiconductor manufacturing processes and existing foundry supply chains.

Deep TechQuantum ComputingSemiconductors

Co-investorsBosch VenturesDCVC (Data Collective)Octopus VenturesOxford Science EnterprisesRobert Bosch Venture CapitalSony Ventures Corporation+3 more

Quralisquralis.comin𝕏Mar 2023

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+7 more

Remoteremote.comin𝕏

Remote helps companies hire, pay, and manage employees internationally by removing barriers to cross-border employment.

Future of WorkHR TechSaaS

Marcelo Lebre(Co-founder & President)inJob van der Voort(Co-founder & CEO)in

Co-investorsAccelB Capital GroupB4 CapitalBase PartnersCategory VenturesDaft Capital+11 more

Robinradarrobinradar.comin

Robin Radar Systems applies radar technology originally developed to detect bird strikes on aircraft, repurposing it for commercial applications in aviation safety and other sectors.

Deep TechDefense TechHardwareIoT

Siete Hamminga(CEO)

Co-investorsSHIFT Invest

Salvia Bioelectronicssalviabioelectronics.comSeries B · May 2025 · $60M

Neuromodulation therapy for migraine relief.

Co-investorsInnovation IndustriesLevensohn Venture PartnersDolby Family Ventures

Scenic Biotechscenicbiotech.comin𝕏

Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtech

Co-investorsBioMedPartnersEIR VenturesOxford Science EnterprisesBioGeneration Ventures

Shapewaysshapeways.comin𝕏

Shapeways provides digital manufacturing services including 3D printing, injection molding, and CNC machining for hardware teams building robotics, drones, medtech, electronics, and defense products.

Advanced ManufacturingE-commerceHardwareEindhoven, NL

Marleen Vogelaar(CEO)inPeter Weijmarshausen(Co-Founder & CEO)inRobert Schouwenburg(CTO)inMartin Meyer(Executive Officer)

BoardJosh Wolfe(Director)inChris Dixon(Director)in

Co-investorsAndreessen HorowitzIndex VenturesLux CapitalMosaic VenturesPresidio VenturesSQN Venture Partners, LLC+1 more

Silverflowsilverflow.comin𝕏

Silverflow provides a cloud-native payment processing platform with a single API connection to the card networks, aimed at reducing cost and complexity for payment processors and their customers.

Cloud ComputingFintechSaaSAmsterdam, NL

Anne Willem De Vries(Founder)inPaul Buying(Co-Founder & CTO)inRobert Kraal(Co-Founder & CBDO)inSaaS Anne Willem De Vries(Founder)

Co-investorsCoatue ManagementCrane Venture PartnersDeBa VenturesPICUS CAPITAL

Splice Biosplice.bioin𝕏Series B · Jun 2025 · $140M

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalAsabys PartnersCriteria Bio Ventures+3 more

TargED Biopharmaceuticalstargedbiopharmaceuticals.cominSeries A · Feb 2022 · $44M

TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.

BiotechMedical DevicesUtrecht, NL

Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in

Co-investorsAndera PartnersCurie CapitalFund+Hadean VenturesRotripBioGeneration Ventures+1 more

Urban Sports Cluburbansportsclub.comin

Urban Sports Club offers a flexible membership giving access to fitness studios and over 50 sports and wellness activities across Europe, bookable via its app for in-person, free-training, or live online sessions.

MarketplacesSports TechWellness & Fitness

Moritz Kreppel(Founder)inBenjamin Roth(Founder)in

Co-investorsb2ventureClaret Capital PartnersPeakRheingau FoundersRTP GlobalSevenVentures+2 more

Wellhubwellhub.comin

Wellhub operates a corporate wellness platform that connects employees to fitness, mindfulness, nutrition, and sleep options through employer-provided plans.

Digital HealthHR TechWellness & Fitness

Cesar Carvalho(CEO & Founder)in

Co-investorsMONASHEESNewView CapitalProvence PartnersSoftbank Latin America FundSoftBank Vision FundValor Capital Group+3 more

Werckerwercker.com

Enabling developers to test and deploy applications with ease

Micha Hernandez van Leuffen(Founder)in

Co-investorsNotion CapitalTola CapitalShamrock Ventures

Withlocalswithlocals.comin𝕏

Withlocals is an online marketplace that connects travelers with local hosts for private, personalized guided tours and food experiences in cities worldwide.

ConsumerMarketplacesTravel & Hospitality

Matthijs Keijin

Co-investorsKeen Venture Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Anavo TherapeuticsBlendleLengooProvable MarketsRainier TherapeuticsSimiBio

Exits · 3

1 IPOs · 2 acquisitions · showing 2

GitLabNASDAQ: GTLBOneacq. by Urban Sports Club

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Inkef made?
Inkef has 51 tracked investments, 3 of which have exited, including 5 dated in the last 24 months.
What stage does Inkef invest at?
Inkef invests at the Seed, Series A, Series B, Series C, Growth stages.
What sectors does Inkef focus on?
Inkef focuses on Biotech, Consumer, Data & Infrastructure, Enterprise Software, Fintech, Healthtech, Media & Entertainment, Medical Devices, New Materials, SaaS.
Where is Inkef located?
Inkef is headquartered in Amsterdam, NL.
Does Inkef lead rounds?
Inkef typically participates in rounds rather than leading them.

Co-investors · 18

BioGeneration Ventures

BioGeneration Ventures is a venture capital firm that invests in early-stage biotech companies in Europe, with a focus on healthcare innovations.

Ysios Capital

Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.

$5.4M – $21.6M
Index Ventures

Index Ventures is a multi-stage venture capital firm that backs companies from Seed to IPO and beyond, including through its dedicated seed fund Index Origin.

Both backed · 2
$540K – $10.8M
Two Sigma Ventures

Two Sigma Ventures has rebranded and is now known as Deviation Capital; the page directs visitors to the new website.

Both backed · 2
$2M – $15M
Sanofi Ventures

Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies focused on improving human health. It serves as Sanofi's entry point into the innovation ecosystem.

Both backed · 2
$5M
Roche Venture Fund

Roche Venture Fund is a corporate venture arm that invests in early-stage biotech and diagnostics companies across more than 10 countries, with a portfolio exceeding 30 portfolio companies. The fund is headquartered in Basel, Switzerland.

Both backed · 2
$648K – $3.2M
Bioqube Ventures

Bioqube Ventures is a global life sciences investment firm with offices in Belgium and the United States, focused on turning scientific discoveries into transformative medicines.

Both backed · 2
AnavotxAnavo Therapeutics
$108K – $6.5M
New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 1
$200K – $40M
Norwest Venture Partners

Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.

Both backed · 1
$10M – $30M
F-Prime Capital

F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.

Both backed · 1
$3M – $10M
Pivotal Life Sciences

Pivotal Life Sciences is an investment platform focused on funding innovative companies developing therapeutic products and technologies aimed at major unmet medical needs.

Both backed · 1
Novartis Venture Fund

The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.

Both backed · 1
$5M – $25M
6 more co-investors

Andera PartnersRiver Venture PartnersHeadlineXtripe AngelsForbionEight Roads Ventures

Firms observed investing alongside Inkef, from public investor directories. Shared companies are the overlap with Inkef's recorded portfolio.

Similar investors

Featured in lists